Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Pharmavite LLC is navigating 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners, showing no overlap in the personnel reviewing the applications. The prosecution occurs across distinct art units, ensuring that strategies are developed independently.
The busiest examiner, NOTTINGHAM, KYLE GREGORY, holds 1 of the pending office actions. Since there are distinct examiners for the pending actions, each professional is managing a portion of the workload. This distribution across distinct art units suggests that the portfolio is not subject to the specific constraints of a particular examination group.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| BOECKELMAN, JACOB A | 1 | 35.2% | +45.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17971542 | TRIBUTYRIN SUPPLEMENTATION PROVIDES BENEFITS FOR MENTAL WELLNESS, IMMUNE HEALTH AND FAT METABOLISM | NOTTINGHAM, KYLE GREGORY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17012009 | OIL-IN-WATER EMULSION GUMMY COMPOSITION | BOECKELMAN, JACOB A | 190d overdue |
| 17971542 | TRIBUTYRIN SUPPLEMENTATION PROVIDES BENEFITS FOR MENTAL WELLNESS, IMMUNE HEALTH AND FAT METABOLISM | NOTTINGHAM, KYLE GREGORY | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17971542 | TRIBUTYRIN SUPPLEMENTATION PROVIDES BENEFITS FOR MENTAL WELLNESS, IMMUNE HEALTH AND FAT METABOLISM | NOTTINGHAM, KYLE GREGORY | 1621 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2022 |
| 17012009 | OIL-IN-WATER EMULSION GUMMY COMPOSITION | BOECKELMAN, JACOB A | 1655 | §103 | Final Rejection | 190d overdue | Pending | Sep 03, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial